In-Hospital Mortality Down With Video-Assisted Thoracoscopic Sx

Share this content:
In-Hospital Mortality Down With Video-Assisted Thoracoscopic Sx
In-Hospital Mortality Down With Video-Assisted Thoracoscopic Sx

WEDNESDAY, Nov. 2, 2016 (HealthDay News) -- Video-assisted thoracoscopic surgery (VATS) lobectomy is associated with lower in-hospital mortality and shorter length of hospital stay versus open thoracotomy, according to a study published online Oct. 25 in the Annals of the American Thoracic Society.

Hem Desai, M.D., from the University of Arizona Health Sciences in Tucson, and colleagues used data from the U.S. Healthcare Cost and Utilization Project Nationwide Inpatient Sample database from 2009 to 2012 to compare outcomes for VATS versus open lobectomy.

Of the 27,451 patients who underwent lobectomy during the study period, 65 percent of procedures were performed by thoracotomy and 35 percent by VATS. A total of 9,393 propensity matched pairs were created. The researchers found that patients undergoing VATS lobectomy had significantly lower in-hospital mortality (1.3 versus 2.5 percent; P < 0.001) and shorter length of hospital stay (6.21 versus 8.75 days; P < 0.001). The overall rate of perioperative complications was low, with the likelihood of any perioperative morbidity lower for those undergoing VATS.

"Use of VATS for lobectomy has increased in recent years relative to thoracotomy. This trend has coincided with increased survival and shorter length of stay for VATS lobectomy compared to thoracotomy," the authors write. "Further studies are needed to identify comorbidities that identify ideal candidates for VATS lobectomy."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Bavencio for Merkel Cell Carcinoma

FDA Approves Bavencio for Merkel Cell Carcinoma

Drug targets the PD-1/PD-L1 pathway; first sanctioned treatment in the United States

Heterogeneous Association for Alcohol, CVD Presentation

Heterogeneous Association for Alcohol, CVD Presentation

Non-drinking linked to increased risks of unstable angina, MI, heart failure, ischemic stroke, PAD, AAA

Mobile App Cuts In-Person Visits After Breast Reconstruction

Mobile App Cuts In-Person Visits After Breast Reconstruction

Number of visits down, increase in e-mails to doctors for ambulatory patients undergoing breast recon

is free, fast, and customized just for you!

Already a member?

Sign In Now »